American Renal Associates LLC

American Renal Associates LLC, doing business as Innovative Renal Care, is the largest integrated dialysis services provider in the United States and operates exclusively as a prime contractor delivering nationwide dialysis services, acute kidney injury care, end-stage renal disease treatment, and comprehensive renal care data reporting to the Department of Veterans Affairs across multiple indefinite delivery contracts, with $6.27 billion in combined potential value across 43 awards and no subcontractor involvement. The company, a for-profit limited liability partnership headquartered in Beverly, Massachusetts, competes in full-and-open federal procurements with no set-aside designations and holds a subsidiary, University Kidney Center, LLC.

American Renal Associates' federal footprint is entirely concentrated with the Veterans Health Administration. The top four customer entities — VHA Veterans Integrated Service Network 8 (8 awards, $3.12 billion combined potential value), VA Headquarters (14 awards, $2.59 billion), VHA Veterans Integrated Service Network 19 (19 awards, $549.7 million), and the Department of Veterans Affairs (2 awards, $13.2 million) — account for 100% of awards. VISN 8, covering the New England region, and VA Headquarters anchor the dollar concentration, while VISN 19 drives volume by count. The company's work spans NAICS 621492 (Kidney Dialysis Centers) and PSC Q999 (Medical-Other), with all 43 awards falling into dialysis and renal care services.

American Renal Associates holds three active VA single-award indefinite delivery contracts. The National Dialysis Service Contract Bridge 2.0, awarded October 1, 2025, carries a $1.197 billion ceiling through September 30, 2026 and has generated nine task orders (18 underlying quarterly EXPRESS REPORT delivery orders) valued at $47.1 million in combined potential value. Its predecessor, the National Dialysis Service Contract Bridge, held a $1.091 billion ceiling through September 30, 2025 and produced 18 task orders with $473.5 million combined potential value. A new multiple-award National Dialysis Service Contracts vehicle, awarded May 13, 2026, carries a $250 million ceiling through September 30, 2031 and has spawned one task order to date. These three vehicles account for 28 of the 43 awards shown. Delivery orders under the active bridges are issued as firm fixed-price contracts on a quarterly or monthly basis, typically valued between $2.4 million and $5.2 million per task order, with completion dates aligned to fiscal quarter or month ends. Recent delivery orders include a $5.2 million February 2026 EXPRESS REPORT order for FY 2026 dialysis data collection and reporting with completion by February 28, 2026; a $19.2 million November 2025 EXPRESS REPORT order for FY 2026 dialysis data, analysis, and nationwide service support with completion by November 30, 2025; and a $15.8 million first-quarter FY 2025 EXPRESS REPORT order issued October 1, 2024 with completion by December 31, 2024. Smaller delivery orders in the $2.4 million to $4.1 million range cover monthly or quarterly EXPRESS REPORT services, including $3.8 million for October 2025 services, $3.94 million for September 2025, and $2.84 million for August 2025 reporting. All work is performed at the company's Beverly, Massachusetts location. Activity has accelerated in recent years—one award in 2022, one in 2023, three in 2024, ten in 2025, and three through May 2026—reflecting expanded delivery order frequency under the bridge contracts. The combined potential value of $6.27 billion against obligated dollars of $256.4 million (4% obligation rate) reflects the unexercised ceiling space across the multiple-award NDSC vehicle and the active bridge contracts, with the Bridge 2.0 carrying performance obligation through September 30, 2026. American Renal Associates executes all awards directly with no documented subcontracting and has no secondary customer agency relationships, creating single-customer concentration and exposure to VA recompete cycles.